Abstract
Amelioration of the valvular geometry is a possible mechanism for mitral regurgitation (MR) improvement in patients receiving cardiac resynchronization therapy (CRT). We aimed to establish the precise definition, incidence, and predictors of reversed mitral remodeling (RMR), as well as the association with MR improvement and short-term CRT outcome. Ninety-five CRT recipients were retrospectively evaluated for the end-point of “MR response” defined as the absolute reduction in regurgitant volume (RegV) at 6 months. To identify RMR, changes in mitral deformation indices were tested for correlation with MR response and further analyzed for functional and echocardiographic CRT outcomes. Overall, MR response was observed in 50 patients (53%). Among the echocardiographic indices, the change in tenting area (TA) had the highest correlation with the change in RegV (r = 0.653, p < 0.001). The mean TA significantly decreased in MR responders (4.15 ± 1.05 to 3.67 ± 1.01 cm2 at 6 months, p < 0.001) and increased in non-responders (3.68 ± 1.04 to 3.98 ± 0.97 cm2, p = 0.014). The absolute TA reduction was used to identify patients with RMR (47%) which was found to be associated with higher rates of functional improvement (p = 0.03) and volumetric CRT response (p = 0.036) compared to those without RMR. Non-ischemic etiology and the presence of LBBB independently predicted RMR at multivariate analysis. In conclusion, reduction in TA is a reliable index of RMR, which relates to MR response, and functional and echocardiographic improvement with CRT. LBBB and non-ischemic etiology are independent predictors of RMR.
Similar content being viewed by others
References
Trichon BH, Felker GM, Shaw LK, Cabell CH, O’Connor CM (2003) Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 91:538–543
Asgar AW, Mack MJ, Stone GW (2015) Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. J Am Coll Cardiol 65(12):1231–1248
Punnoose L, Burkhoff D, Cunningham L, Horn EM (2014) Functional mitral regurgitation: therapeutic strategies for a ventricular disease. J Card Fail 20(4):252–267
D’ascenzo F, Moretti C, Marra WG, Montefusco A, Omede P, Taha S, Castagno D, Gaemperli O, Taramasso M, Frea S, Pidello S, Rudolph V, Franzen O, Braun D, Giannini C, Ince H, Perl L, Zoccai G, Marra S, D’Amico M, Maisano F, Rinaldi M, Gaita F (2015) Meta-analysis of the usefulness of Mitraclip in patients with functional mitral regurgitation. Am J Cardiol 116(2):325–331
Kato Y, Bando K, Fukui T, Mahara K, Takanashi S (2015) Surgical treatment of functional mitral regurgitation involving the subvalvular apparatus. J Card Surg 30(1):27–34
van Bommel RJ, Marsan NA, Delgado V, Borleffs CJ, van Rijnsoever EP, Schalij MJ, Bax JJ (2011) Cardiac resynchronization therapy as a therapeutic option in patients with moderate-severe functional mitral regurgitation and high operative risk. Circulation 124:912–919
Di Biase L, Auricchio A, Mohanty P, Bai R, Kautzner J, Pieragnoli P, Regoli F, Sorgente A, Spinucci G, Ricciardi G, Michelucci A, Perrotta L, Faletra F, Mlcochová H, Sedlacek K, Canby R, Sanchez JE, Horton R, Burkhardt JD, Moccetti T, Padeletti L, Natale A (2011) Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. Europace 13:829–838
Sitges M, Vidal B, Delgado V, Mont L, Garcia-Alvarez A, Tolosana JM, Castel A, Berruezo A, Azqueta M, Pare C, Brugada J (2009) Long-term effect of cardiac resynchronization therapy on functional mitral valve regurgitation. Am J Cardiol 104:383–388
Porciani MC, Macioce R, Demarchi G, Chiostri M, Musilli N, Cappelli F, Lilli A, Ricciardi G, Padeletti L (2006) Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure. Eur J Echocardiogr 7:31–39
Ypenburg C, Lancellotti P, Tops LF, Boersma E, Bleeker GB, Holman ER, Thomas JD, Schalij MJ, Piérard LA, Bax JJ (2008) Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy. Eur Heart J 29:757–765
Kanzaki H III, Bazaz R, Schwartzman D, Dohi K, Sade LE, Gorcsan J III (2004) A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy: insights from mechanical activation strain mapping. J Am Coll Cardiol 44:1619–1625
Liang YJ, Zhang Q, Fung JW, Chan JY, Yip GW, Lam YY, Yu CM (2010) Impact of reduction in early- and late-systolic functional mitral regurgitation on reverse remodelling after cardiac resynchronization therapy. Eur Heart J 31:2359–2368
Ypenburg C, Lancellotti P, Tops LF, Bleeker GB, Holman ER, Piérard LA, Schalij MJ, Bax JJ (2007) Acute effects of initiation and withdrawal of cardiac resynchronization therapy on papillary muscle dyssynchrony and mitral regurgitation. J Am Coll Cardiol 50(21):2071–2077
Upadhyay GA, Chatterjee NA, Kandala J, Friedman DJ, Park MY, Tabtabai SR, Hung J, Singh JP (2015) Assessing mitral regurgitation in the prediction of clinical outcome after cardiac resynchronization therapy. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2015.02.022
Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, Gorenek B, Israel CW, Leclercq C, Linde C, Mont L, Padeletti L, Sutton R, Vardas PE (2013) 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Europace 15:1070–1118
Pino PG, Galati A, Terranova A (2006) Functional mitral regurgitation in heart failure. J Cardiovasc Med 7(7):514–523
Strauss DG, Selvester RH, Wagner GS (2011) Defining left bundle branch block in the era of cardiac resynchronization therapy. Am J Cardiol 107(6):927–934
Dong YX, Powell BD, Asirvatham SJ, Friedman PA, Rea RF, Webster TL, Brooke KL, Hodge DO, Wiste HJ, Yang YZ, Hayes DL, Cha YM (2012) Left ventricular lead position for cardiac resynchronization: a comprehensive cinegraphic, echocardiographic, clinical, and survival analysis. Europace 14:1139–1147
Barold SS, Ilercil A, Herweg B (2008) Echocardiographic optimization of the atrioventricular and interventricular intervals during cardiac resynchronization. Europace 10(Suppl 3):iii88–iii95
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233–270
Enriquez-Sarano M, Miller FA Jr, Hayes SN, Bailey KR, Tajik AJ, Seward JB (1995) Effective mitral regurgitant orifice area: clinical use and pitfalls of the proximal isovelocity surface area method. J Am Coll Cardiol 25:703–709
Karaca O, Avci A, Guler GB, Alizade E, Guler E, Gecmen C, Emiroglu Y, Esen O, Esen AM (2011) Tenting area reflects disease severity and prognosis in patients with non-ischaemic dilated cardiomyopathy and functional mitral regurgitation. Eur J Heart Fail 13(3):284–291
Sadeghpour A, Abtahi F, Kiavar M, Esmaeilzadeh M, Samiei N, Ojaghi SZ, Bakhshandeh H, Maleki M, Noohi F, Mohebbi A (2008) Echocardiographic evaluation of mitral geometry in functional mitral regurgitation. J Cardiothorac Surg 3:54
Debonnaire P, Al Amri I, Leong DP, Joyce E, Katsanos S, Kamperidis V, Schalij MJ, Bax JJ, Marsan NA, Delgado V (2015) Leaflet remodelling in functional mitral valve regurgitation: characteristics, determinants, and relation to regurgitation severity. Eur Heart J Cardiovasc Imaging 16(3):290–299
Nagasaki M, Nishimura S, Ohtaki E, Kasegawa H, Matsumura T, Nagayama M, Koyanagi T, Tohbaru T, Misu K, Asano R, Sumiyoshi T, Hosoda S (2006) The echocardiographic determinants of functional mitral regurgitation differ in ischemic and non-ischemic cardiomyopathy. Int J Cardiol 108(2):171–176
Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Tajik AJ (2000) Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation 102(12):1400–1406
Nickenig G, Schueler R, Dager A, Martinez Clark P, Abizaid A, Siminiak T, Buszman P, Demkow M, Ebner A, Asch FM, Hammerstingl C (2016) Treatment of chronic functional mitral valve regurgitation with a percutaneous annuloplasty system. J Am Coll Cardiol 67(25):2927–2936
Liang YJ, Zhang Q, Fung JW, Chan JY, Yip GW, Lam YY, Lee AP, Yu CM (2010) Different determinants of improvement of early and late systolic mitral regurgitation contributed after cardiac resynchronization therapy. J Am Soc Echocardiogr 23(11):1160–1167
Matsumoto K, Tanaka H, Okajima K, Hayashi T, Kajiya T, Kawai H, Hirata K (2011) Relation between left ventricular morphology and reduction in functional mitral regurgitation by cardiac resynchronization therapy in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 108(9):1327–1334
Madaric J, Vanderheyden M, Van Laethem C, Verhamme K, Feys A, Goethals M, Verstreken S, Geelen P, Penicka M, De Bruyne B, Bartunek J (2007) Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance. Eur Heart J 28(17):2134–2141
Hsu JC, Solomon SD, Bourgoun M, McNitt S, Goldenberg I, Klein H, Moss AJ, Foster E (2012) Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. J Am Coll Cardiol 59(25):2366–2373
Killu AM, Grupper A, Friedman PA, Powell BD, Asirvatham SJ, Espinosa RE, Luria D, Rozen G, Buber J, Lee YH, Webster T, Brooke KL, Hodge DO, Wiste HJ, Glikson M, Cha YM (2014) Predictors and outcomes of “super-response” to cardiac resynchronization therapy. J Card Fail 20(6):379–386. https://doi.org/10.1016/j.cardfail.2014.03.001
Imamura T, Kinugawa K, Nitta D, Komuro I (2015) Complete left bundle branch block and smaller left atrium are predictors of response to cardiac resynchronization therapy in advanced heart failure. Circ J 79(11):2414–2421
Rickard J, Kumbhani DJ, Popovic Z, Verhaert D, Manne M, Sraow D, Baranowski B, Martin DO, Lindsay BD, Grimm RA, Wilkoff BL, Tchou P (2010) Characterization of super-response to cardiac resynchronization therapy. Heart Rhythm 7(7):885–889
Auricchio A, Schillinger W, Meyer S, Maisano F, Hoffmann R, Ussia GP, Pedrazzini GB, van der Heyden J, Fratini S, Klersy C, Komtebedde J, Franzen O (2011) PERMIT-CARE Investigators. Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling. J Am Coll Cardiol 58(21):2183–2189
Jensen H, Jensen MO, Nielsen SL (2015) Surgical treatment of functional ischemic mitral regurgitation. J Heart Valve Dis 24(1):30–42
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that there are no conflicts of interest.
Rights and permissions
About this article
Cite this article
Karaca, O., Cakal, B., Omaygenc, M.O. et al. Effect of cardiac resynchronization therapy on mitral valve geometry: a novel aspect as "reversed mitral remodeling". Int J Cardiovasc Imaging 34, 1029–1040 (2018). https://doi.org/10.1007/s10554-018-1308-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-018-1308-2